Details for Patent: 5,559,148
✉ Email this page to a colleague
Summary for Patent: 5,559,148
| Title: | Parenteral busulfan for treatment of malignant disease |
| Abstract: | Stable parenteral formulations of busulfan for parenteral administration are disclosed. The improved bioavailability of the parenteral formulations optimizes high dose busulfan therapy against malignant disease and improves the safety of such therapy. |
| Inventor(s): | Andersson; Borje S. (Houston, TX), Bhagwatwar; Harshal P. (Houston, TX), Chow; Diana S. (Houston, TX) |
| Assignee: | Board of Regents, The University of Texas System (Austin, TX) University of Houston-University Park (Houston, TX) |
| Application Number: | 08/449,685 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Composition; Dosage form; |
Drugs Protected by US Patent 5,559,148
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,559,148
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 197670 | ⤷ Try a Trial | |||
| Australia | 694141 | ⤷ Try a Trial | |||
| Australia | 7829094 | ⤷ Try a Trial | |||
| Canada | 2171738 | ⤷ Try a Trial | |||
| Germany | 69426334 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
